Company news
Corcept Therapeutics Incorporated news in 2020
Corcept Therapeutics Incorporated's news releases, calls and decks from 2020, newest first.
Corcept Therapeutics Appoints Gillian M. Cannon, PhD, to Board of Directors
November 22, 2020
U.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept’s U.S. Patent No.10,195,214
November 17, 2020
Corcept Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 2, 2020
Corcept Therapeutics Initiates Second Phase 2 Trial of Miricorilant to Treat Weight Gain Caused by Antipsychotic Medication
September 9, 2020
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
August 3, 2020
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushing’s Syndrome of Adrenal Origin
July 27, 2020
Corcept Therapeutics Completes Enrollment in Controlled, Phase 2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Ovarian Cancer
July 22, 2020
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
June 29, 2020
Corcept Therapeutics to Present Data at the American Association of Cancer Research Annual Meeting
June 14, 2020
Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting
May 13, 2020
Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update
May 3, 2020
Corcept Therapeutics publishes abstract in the journal of the Endocrine Society
March 31, 2020
Corcept Therapeutics Appoints Gregg Alton to Board of Directors
March 11, 2020
Corcept Therapeutics Announces Fourth Quarter And Full-Year 2019 Audited Financial Results And Provides Corporate Update
February 19, 2020
Corcept Therapeutics to Announce Audited Financial Results, Provide Corporate Update and Host Conference Call
February 12, 2020
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2019 Preliminary Selected Financial Results; Provides 2020 Revenue Guidance
January 29, 2020